In particular, the dysfunction of CTCF caused by the K334E mutation in breast cancer has been associated with the onset of the disease47, which could affect its ability to bind to the promoter of genes related to cell proliferation including MYC, PLK, and p19ARF48. This evidence concerns the gene CTCF and breast cancer.